1. Translating Benzodiazepine Utilization Data into Meaningful Population Exposure: Integration of Two Metrics for Improved Reporting

   • Jaden Brandt
   • Wajd Alkabanni
   • Christine Leong

   Current Opinion 04 April 2018 Pages: 565 - 572

   

2. Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?

   • Aaron J. Salwan
   • Nicholas E. Hagemeier
   • Sam Harirforoosh

   Current Opinion 12 April 2018 Pages: 573 - 577

3. Interventions and Strategies to Improve Oral Anticoagulant Use in Patients with Atrial Fibrillation: A Systematic Review of Systematic Reviews

   • Siok Shen Ng
   • Nai Ming Lai
   • Nathorn Chaiyakunapruk

   Systematic Review 22 March 2018 Pages: 579 - 591

   

4. Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease

   • Annalisa Biffi
   • Lorenza Scotti
   • on behalf of the Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE)

   Original Research Article 27 March 2018 Pages: 593 - 602

   

5. Impact of Anthracyclines on Diabetes Mellitus Development in B-Cell Lymphoma Patients: A Nationwide Population-based Study

   • Chieh-Lin Jerry Teng
   • Kuang-Hsi Chang
   • Wayne H-H Sheu

   Original Research Article 09 April 2018 Pages: 603 - 610

   

6. Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment

   • Margarita Capel
   • María Mareque
   • Itziar Oyagüez

   Original Research Article 13 April 2018 Pages: 611 - 620

   

7. Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries

   • Bin Wu
   • Ruoyan Gai Tobe
   • Ben He

   Original Research Article 30 April 2018 Pages: 621 - 630

   

8. Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men

   • Ka Lai Yee
   • Jacqueline McCrea
   • Rebecca E. Wrishko

   Original Research Article 28 April 2018 Pages: 631 - 638

   

9. Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study

   • Ekaterini C. Tampaki
   • Athanasios Tampakis
   • Dimitrios T. Trafalis

   Original Research Article 09 May 2018 Pages: 639 - 648

   

10. Acetazolamide and Cardiac Failure

    • Nevio Cimolai

    Letter to the Editor 07 May 2018 Pages: 649 - 650

11. Response to “Acetazolamide and Cardiac Failure”

    • Tomasz Imiela
    • Andrzej Budaj

    Letter to the Editor Open access 07 May 2018 Pages: 651 - 651